StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.46−0.09 (-15.97%)

Close on Nov 17, 2026Market cap $830.71KP/E –Yield –

Aptevo Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aptevo Therapeutics's price to book ratio was 0.2× on Nov 11, 2026, against 1.1× a year earlier. Over the last 4 years it ranged from 0.2× to 475.1×, with a median of 3.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×−0.2
2025Dec 31, 20250.4×−8.6
2024Dec 31, 20249.0×−147.5
2023Dec 29, 2023156.5×−227.8
2019Apr 30, 2019384.3×−76.4
2018Dec 31, 2018460.7×+72.9
2017Aug 31, 2017387.8×−36.8
2016Nov 30, 2016424.6×–

More Aptevo Therapeutics figures

See a number that looks wrong?